By Elric Langton | 16 January 2023
I have a financial interest in Poolbeg Pharma.
Poolbeg announces strategic expansion of POLB 001 into oncology.
Poolbeg Pharma (AIM: POLB, OTCQB: POLBF), a leading infectious disease-focused biopharmaceutical company, announces the strategic expansion of POLB 001 into oncology. While investigating the role of cytokine relβ¦